Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (4): 1-9.doi: 10.6040/j.issn.1671-7554.0.2022.1226

• 基础医学 •    

ACE2 gene protects against renal ischemia-reperfusion injury by regulating the Nrf2/HO-1 signaling pathway

ZHANG Jiaying, SU Rongyun, WANG Yinghui, WANG Honggang, LIU Gang   

  1. Department of Nephrology, The Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Published:2023-04-11

Abstract: Objective To investigate the effects of angiotensin-converting enzyme 2(ACE2)on the oxidative stress, inflammation, apoptosis and the nuclear factor E2-related factor 2(Nrf2)/ heme oxygenase 1(HO-1)signaling pathway in renal tubular epithelial cells(HK-2)induced by hypoxia/reoxygenation(H/R). Methods HK-2 cells were transfected with ACE2 lentivirus, and divided into the control group, H/R group, H/R-NC group, and H/R-ACE2 group. After H/R treatment, cell viability was measured with CCK-8 assay; the levels of inflammatory factors including interleukin-6(IL-6), tumor necrosis factor-α(TNF-α)and interleukin-1β(IL-1β)were measured with ELISA and RT-PCR; superoxide dismutase(SOD)and malondialdehyde(MDA)levels were measured with colorimetric assay; protein levels of Caspase-3, Bcl-2, Bax, Nrf2, and HO-1 were measured with Western blotting. After ML385 and SnPPIX were used to inhibit the Nrf2/HO-1 pathway, changes in the expressions of Caspase-3, Bcl-2, Bax, Nrf2 and HO-1 were detected with Western blotting, and changes in SOD and MDA levels were detected with colorimetry. Results Compared with the control group, the H/R group showed lower cell viability(t=7.58, P<0.001), higher expression levels of MDA, IL-1β, IL-6, TNF-α, Caspase-3 and Bax(tMDA=11.08, PMDA<0.001; tPCR-IL-6=5.82, PPCR-IL6<0.001; tPCR-TNF-α=7.69, PPCR-TNF-α<0.001; tPCR-IL-1β=4.80, PPCR-IL-1β=0.001; tELISA-IL-6=34.11, PELISA-IL-6<0.001; tELISA-TNF-α=14.12, PELISA-TNF-α<0.001; tELISA-IL-1β=9.63, PELISA-IL-1β<0.001; tCaspase-3=2.73, PCaspase-3=0.026; tBax=27.75, PBax<0.001), but lower levels of SOD, Bcl-2 and ACE2(tSOD=7.74, PSOD<0.001; tBcl-2=75.49, PBcl-2<0.001; tACE2=11.41, PACE2<0.001). Compared with the H/R group, the H/R-ACE2 group had higher cell viability(t=3.61, P=0.002), lower levels of MDA, IL-1β, IL-6, TNF-α, Caspase-3 and Bax(tMDA=6.15, PMDA<0.001; tPCR-IL-6=3.34, PPCR-IL6=0.006; tPCR-TNF-α=3.65, PPCR-TNF-α=0.007; tPCR-IL-1β=4.06, PPCR-IL-1β=0.004; tELISA-IL-6=14.62, PELISA-IL-6<0.001; tELISA-TNF-α=10.42, PELISA-TNF-α<0.001; tELISA-IL-1β=8.65, PELISA-IL-1β<0.001; tCaspase-3=3.74, PCaspase-3=0.006; tBax=30.52, PBax<0.001), higher levels of SOD, Bcl-2, ACE2, Nrf2, and HO-1(tSOD=3.58, PSOD=0.007; tBcl-2=63.86, PBcl-2<0.001; tACE2=58.72, PACE2<0.001; tNrf2=44.55, PNrf2<0.001; tHO-1=14.19, PHO-1<0.001). However, ML385 and SnPPIX inhibited the protective effects of ACE2 gene overexpression on HK-2 cells under H/R(FBax=11.02, PBax=0.003; FBcl-2=21.48, PBcl-2<0.001; FCaspase-3=20.80, PCaspase-3<0.001; FSOD=133.49, PSOD<0.001; FMDA=14.06, PMDA=0.001). Conclusion ACE2 inhibits the oxidative stress, regulates inflammation, and ameliorates apoptosis in HK-2 cells under H/R, and the Nrf2/HO-1 signaling pathway may play an important role in this progress.

Key words: Angiotensin-converting enzyme 2, Ischemia-reperfusion injury, Oxidative stress, Apoptosis, Signaling pathway

CLC Number: 

  • R574
[1] Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes [J]. Kidney Int, 2012, 81(9): 819-825.
[2] Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults [J]. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
[3] Liu KD, Goldstein SL, Vijayan A, et al. AKI!Now initiative: recommendations for awareness, recognition, and management of AKI [J]. Clin J Am Soc Nephrol, 2020, 15(12): 1838-1847.
[4] Farrar A. Acute kidney injury [J]. Nurs Clin North Am, 2018, 53(4): 499-510.
[5] He L, Wei Q, Liu J, et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms [J]. Kidney Int, 2017, 92(5): 1071-1083.
[6] Sharma N, Anders HJ, Gaikwad AB. Fiend and friend in the renin angiotensin system: an insight on acute kidney injury [J]. Biomed Pharmacother, 2019, 110: 764-774. doi: 10.1016/j.biopha.2018.12.018.
[7] Verano-Braga T, Martins ALV, Motta-Santos D, et al. ACE2 in the renin-angiotensin system [J]. Clin Sci(Lond), 2020, 134(23): 3063-3078.
[8] Yamamoto K, Takeshita H, Rakugi H. ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19 [J]. Clin Sci(Lond), 2020, 134(22): 3047-3062.
[9] Hikmet F, Méar L, Edvinsson Å, et al. The protein expression profile of ACE2 in human tissues [J]. Mol Syst Biol, 2020, 16(7): e9610. doi: 10.15252/msb.20209610.
[10] Nath KA, Singh RD, Grande JP, et al. Expression of ACE2 in the intact and acutely injured kidney [J]. Kidney360, 2021, 2(7): 1095-1106.
[11] Fang F, Liu GC, Zhou X, et al. Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury [J]. PLoS One, 2013, 8(8): e71433. doi: 10.1371/journal.pone.0071433.
[12] Yan S, Ye P, Aleem MT, et al. Mesenchymal stem cells overexpressing ACE2 favorably ameliorate LPS-induced inflammatory injury in mammary epithelial cells [J]. Front Immunol, 2022, 12: 796744. doi: 10.3389/fimmu.2021.796744.
[13] Rodrigues Prestes TR, Rocha NP, Miranda AS, et al. The anti-inflammatory potential of ACE2/angiotensin-(1-7)/Mas receptor axis: evidence from basic and clinical research [J]. Curr Drug Targets, 2017, 18(11): 1301-1313.
[14] Kuba K, Yamaguchi T, Penninger JM. Angiotensin-converting enzyme 2(ACE2)in the pathogenesis of ARDS in COVID-19 [J]. Front Immunol, 2021, 12: 732690. doi: 10.3389/fimmu.2021.732690.
[15] Kaltenecker CC, Domenig O, Kopecky C, et al. Critical role of neprilysin in kidney angiotensin metabolism [J]. Circ Res, 2020, 127(5): 593-606.
[16] Imai Y, Kuba K, Ohto-Nakanishi T, et al. Angiotensin-converting enzyme 2(ACE2)in disease pathogenesis [J]. Circ J, 2010, 74(3): 405-410.
[17] Kumar R, Thomas CM, Yong QC, et al. The intracrine renin-angiotensin system [J]. Clin Sci(Lond), 2012, 123(5): 273-284.
[18] Herr D, Bekes I, Wulff C. Local renin-angiotensin system in the reproductive system [J]. Front Endocrinol(Lausanne), 2013, 4: 150. doi: 10.3389/fendo.2013.00150.
[19] Liu C, Chen K, Wang H, et al. Gastrin attenuates renal ischemia/reperfusion injury by a PI3K/Akt/Bad-mediated anti-apoptosis signaling [J]. Front Pharmacol, 2020, 11: 540479. doi: 10.3389/fphar.2020.540479.
[20] Jun W, Benjanuwattra J, Chattipakorn SC, et al. Necroptosis in renal ischemia/reperfusion injury: a major mode of cell death? [J]. Arch Biochem Biophys, 2020, 689: 108433. doi: 10.1016/j.abb.2020.108433.
[21] Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury [J]. Transplantation, 2002, 73(11): 1693-1700.
[22] Daemen MA, vant Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation [J]. J Clin Invest, 1999, 104(5): 541-549.
[23] He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond[J]. Int J Mol Sci, 2020, 21(13): 4777. doi: 10.3390/ijms21134777.
[24] Bellezza I, Giambanco I, Minelli A, et al. Nrf2-Keap1 signaling in oxidative and reductive stress[J]. Biochim Biophys Acta Mol Cell Res, 2018, 1865(5): 721-733.
[25] Gallorini M, Petzel C, Bblay C, et al. Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability[J]. Biomaterials, 2015, 56: 114-128. doi: 10.1016/j.biomaterials.2015.03.047.
[26] Chiang SK, Chen SE, Chang LC. A dual role of heme oxygenase-1 in cancer cells[J]. Int J Mol Sci, 2018, 20(1): 39. doi: 10.3390/ijms20010039.
[27] Mansouri A, Reiner Ž, Ruscica M, et al. Antioxidant effects of statins by modulating Nrf2 and Nrf2/HO-1 signaling in different diseases[J]. J Clin Med, 2022, 11(5): 1313. doi: 10.3390/jcm11051313.
[1] LU Xiang-Dong, YANG Wei, XU Guang-Meng, QU Yuan-Ming. Expression and role of PPAR-γin meningiomas and troglitazone induced meningiomas cell apoptosis in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 65-.
[2] ZHAO Kai, YIN Xinbao, ZHANG Zongliang, WANG Zhenlin, ZHU Guanqun, WANG Ke. Inhibitory effect and mechanism of astragaloside Ⅱ on renal clear cell carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2023, 61(1): 10-16.
[3] ZHAO Ge, ZOU Cunhua, SONG Dongdong, ZHAO Shuping. Effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 53-58.
[4] ZOU Pinheng, CHEN Tianguo, HU Kang, LI Weicai. Effects and mechanism of overexpression of miR-27a on hippocampal neuronal injury in rats with acute cerebral infarction [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 59-66.
[5] WU Hong, ZHANG Zhengduo, TANG Yanjin, QI Shaojun, GAO Xibao. Potential intervention effects of 5-methyltetrahydrofolate on atherosclerosis in rats [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 6-13.
[6] ZHANG Bingfen, ZHOU Shenghong, WANG Zhe. Trillium Saponins ameliorates pulmonary fibrosis in rats by inhibiting TGF-β/Smad3 and Wnt/β-catenin signaling pathways [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 23-29.
[7] XIANG Yujiao, LIU Qiang, LIU Lu, SHI Yan. Mechanism of abnormal immune response of dendritic cells in immune thrombocytopenia [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 89-97.
[8] LIU Min, ZHANG Yuchao, MA Xiaoli, LIU Xinyu, SUN Lu, ZUO Dan, LIU Yuantao. Effects of orphan nuclear receptor NR4A1 on H2O2 induced injury of mouse renal podocytes [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 16-21.
[9] HU Na, SUN Miao, XING Shasha, XU Danxia, HAI Xiaoming, MA Ling, YANG Li, MIAN Yuchen, HE Rui, CHEN Dongmei, MA Huiming. Evening primrose oil resists oxidative stress in the ovaries of rats with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 22-30.
[10] ZENG Yuanyuan, YANG Dongpeng, DONG Zhu, ZHANG Ben, CAO Yiqiu, WANG Xiaowu. Effects and mechanism of tetramethylpyrazine on monocrotaline induced pulmonary arterial hypertension in rats [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 63-69.
[11] FENG Haigang, LIU Guowen, CAO Hong. Effects and mechanism of interfering MAD2L1 gene expression on the apoptosis of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 9-16.
[12] LI Hui, JIANG Chaoyang, LIU Yan, ZHANG Man. Effects and mechanism of histone deacetylase SIRT1 controlled macrophage apoptosis induced by oxidized low density lipoprotein [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 6-12.
[13] HUANG Huining, DU Juanjuan, SUN Yi, HOU Yinglong, GAO Mei. Hydrogen sulfide alleviates acute obstructive sleep apnea-induced atrial fibrillation by regulating oxidative stress through glutaredoxin-1 [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 1-5.
[14] WANG Fang, CHEN Hua, SHANG Lihong, LI Ruyue, LI Yongmei, YANG Yu,e, HA Chunfang. Effects of U0126 on MEK/ERK/NF-κB pathway, proliferation and invasion in rats with endometriosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 148-154.
[15] LI Minqi, DU Juan, YANG Panpan, KOU Yuying, LIU Shanshan. Research progress of oxidative stress regulating osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 16-24.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!